Alzheimer's disease (AD) is associated with cognitive impairment and dementia, both of which are widespread in the elderly population due to neurodegeneration. It slowly deteriorates the patient's memory. The development of senile plaques and neurofibrillary tangles are important diagnostic findings (NFTs). The inability of the neurotransmitter acetylcholine (ACh) to function in the cerebral region is due to metabolism by an enzyme called acetylcholine esterase, and neuronal death is the primary cause of AD. There are numerous anti-medication Alzheimer's categories on the market for the management of Alzheimer's disease; however, satisfactory outcomes have not been found due to a lack of patient compliance. Herbal medicines are becoming more popular owing to their alleged efficacy, safety, and inexpensive cost. Due to the ageing population and increased frequency of Alzheimer's disease, it appears that new treatment drugs with the highest efficacy and fewest side effects are necessary.